Close

Merit Medical Systems announced Three-Part Deal With Vysera Biomedical Limited

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

EHR Health IT Solutions Among Others Impacting Patient Fate

EHR Health IT solutions and also telehealth platforms, patient...

EHRA asks HHS to Modernizing the Regulatory Approach to RFI

The HIMSS Electronic Health Record Association in the US...

AI in Patient Engagement Clocking Around 22% CAGR by 2029

AI in patient engagement – market size in 2029 Let...

Medical Device Manufacturers to Boost in Saudi Arabia

The Ministry of Industry and Mineral Resources of Saudi...

Merit Medical Systems, Inc, a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and gastroenterology procedures, announced today that the Company has completed a three-part deal with Vysera Biomedical Limited located in Galway, Ireland, which will give Merit access to certain intellectual property and know-how for valve technology, opportunities to commercialize certain biomaterial technology and equity ownership in Vysera.

The transactions provide Merit with an exclusive license for certain valve technology that may be incorporated into non-vascular stents, specifically esophageal stents, to address acid reflux conditions. Secondly, the transactions provide Merit with an exclusive license for the development and use of certain biomaterial technology for the coating of selected non-vascular stents and gastrointestinal and drainage catheters.

Finally, the transactions provide Merit with an equity investment of approximately $2.4 million, which will give Merit an approximate 14.45% fully-diluted participating equity interest in Vysera. Additionally, Fred P. Lampropoulos, Merit's Chairman and Chief Executive Officer, has been elected as a director of Vysera.

Latest stories

Related stories

EHR Health IT Solutions Among Others Impacting Patient Fate

EHR Health IT solutions and also telehealth platforms, patient...

EHRA asks HHS to Modernizing the Regulatory Approach to RFI

The HIMSS Electronic Health Record Association in the US...

AI in Patient Engagement Clocking Around 22% CAGR by 2029

AI in patient engagement – market size in 2029 Let...

Medical Device Manufacturers to Boost in Saudi Arabia

The Ministry of Industry and Mineral Resources of Saudi...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back